相关实验视频
Updated: Jan 8, 2026
06:41
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
12.9K
阿根廷创伤外体膜氧化:并发症,死亡率和长期结果
Federico Carini1, Débora Belén Ávila Poletti1, Sofía Schverdfinger1
1From the Intensive Care Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
ASAIO journal (American Society for Artificial Internal Organs : 1992)
|December 11, 2025
概括
拉丁美洲创伤患者的体外膜氧化 (ECMO) 显示了59%的生存率. 幸存者长期保持了功能独立,尽管经常有疼痛和焦虑,这凸显了对创伤特定护理的需要.
科学领域:
- 关键护理医学 关键护理医学
- 创伤外科 手术 创伤外科
- 支持心肺血管的支持.
背景情况:
- 在拉丁美洲,外体膜氧化 (ECMO) 在创伤患者中的使用报告不足.
- 多创伤与难治性呼吸衰竭需要先进的生命支持.
研究的目的:
- 评估拉丁美洲创伤患者的ECMO并发症,死亡率和预后得分表现.
- 评估创伤ECMO幸存者的长期生活质量 (QoL).
主要方法:
- 在阿根廷接受静脉静脉ECMO的31名成年多创伤患者的回顾性队列研究 (2015-2024).
- 对ECMO相关并发症,住院死亡率和确定的预后得分 (ISS,APACHE II,RESP) 的分析.
- 在幸存者中使用EQ-5D-3L和Katz指数对长期QOL的前性评估.
主要成果:
- 住院死亡率为38.7%. 常见的并发症包括出血 (25.8%) 和血栓形成 (22.6%).
- 预测得分显示了适度的歧视 (AUROC 0.53-0.62).
- 在长期随访的11名幸存者中 (中位数为7年),QOL保持 (EQ-5D-3L效用0.743),具有独立的功能状态 (卡茨指数6).
结论:
- 在拉丁美洲,ECMO在ARDS严重创伤的住院生存率达到59%,幸存者具有持久的功能状态.
- 已建立的预后模型在这个人群中表现有限,这表明需要创伤特定工具.
- 结构化康复和后续对ECMO治疗的创伤患者至关重要.
相关概念视频
01:26Flail Chest-II
488
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
488
01:29Acute Respiratory Failure-V
421
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
421